4/A//SEC Filing
Machatha Stephen 4/A
Accession 0000950170-24-045113
CIK 0001341235other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:12 PM ET
Size
6.0 KB
Accession
0000950170-24-045113
Insider Transaction Report
Form 4/AAmended
Machatha Stephen
Chief Development Officer
Transactions
- Sale
Common Stock
2024-03-12$3.16/sh−11,537$36,503→ 252,812 total
Footnotes (3)
- [F1]These shares of common stock were sold by the Reporting Person for tax withholding and tax planning purposes in connection with the settlement of certain time-based restricted stock unit awards. This sale was previously reported in the Reporting Person's Form 4 filed on March 12, 2024 (the "Original Form 4").
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.31. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Adjusted to reflect 9,317 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan, which were inadvertently omitted in the Original Form 4. The amount in Column 5 of this Form 4 reflects the number of shares beneficially owned by the Reporting Person as of the date of this report after giving effect to the adjustment.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001836354
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:12 PM ET
- Size
- 6.0 KB